(11-413) De-escalation of Incretin Based Therapy: Implications for Weight, Glycemic Control, and Safety in Patients with Type 2 Diabetes Mellitus in Ambulatory Care Clinics
Wednesday, December 10, 2025
12:30 PM - 1:30 PM
Location: Bayside A, Level 1
Residency Program: One Brooklyn Health Residency Program Type: PGY2 (Ambulatory Care Pharmacy) Residency Program Location: New York
